Clinical trials
Withdrawn Phase 3 Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| EMS | 6 |
| Bayer | 2 |
| Alvogen Korea | 1 |
| Eurofarma Laboratorios S.A. | 1 |
| Idorsia Pharmaceuticals Ltd. | 1 |
| Novartis Pharmaceuticals | 1 |
| PRM Pharma, LLC | 1 |
| Sarfez Pharmaceuticals, Inc. | 1 |
| Takeda | 1 |
| The Medicines Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 18 |
| Diabetes Mellitus, Type 2 | 3 |
| Diabetic Nephropathies | 1 |
| Dyslipidemias | 1 |
| Dyspnea | 1 |
| Glucose Intolerance | 1 |
| Hypercholesterolemia | 1 |
| Proteinuria | 1 |
| Renal Insufficiency, Chronic | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.